India's Laurus Labs hits record high as Q2 profit more than doubles

Laurus Labs

30/10/2026 09:00

** India's Laurus Labs LAUL.NS jumps 6.3% to record high of 2,385.8 rupees
** Co's Q2 net profit more than doubles to 4.4 billion rupees ($46.30 million), revenue jumps 33%
** Strength in contract development and manufacturing organization (CDMO) segment, favourable product mix and improving operational leverage boost earnings, Laurus Labs says
** Motilal Oswal Financial Services raises earnings estimate by 28% and 30% for FY27 and FY28, respectively, factoring in the scale-up of CDMO segment, including peptide manufacturing and uptick in affordable medicine supply
** More than 6.6 million shares change hands, ~4x of 30-day average daily volume
** Stock rated "hold" on average by 12 brokerage firms, median PT at 1,855 rupees, per data compiled by LSEG
** YTD, LAUL up 115%


($1 = 95.0250 Indian rupees)

 (Reporting by Vivek Kumar M)
 ((VivekKumar.M@thomsonreuters.com;))